| |
|
|
|
RedHill Biopharma Ltd.  
|
|
6.09 -0.2 (-0.03%) |
10-16 16:00 |
|
Open: |
6.3089 |
Pre close: |
6.29 |
Target:
|
8.38 
|
|
High: |
6.4 |
Low: |
6.06 |
Resistance:
|
7.17
8.13
|
|
Volume: |
63,280 |
Market Cap: |
178M |
Support:
|
5.63
4.68
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.17
|
MACD |
MACD(12,26):
|
-0.35 |
|
MA(20): |
6.90 |
Signal(12,26,9): |
-0.25 |
|
MA(100): |
7.15 |
Stochastic Oscillator |
%K(14,3):
|
29.05  |
|
MA(250): |
7.55 |
%D(3): |
23.06 |
|
Average Volume(K) |
3-Month: |
5865
|
52-Week |
High:
|
9.57 |
|
10-Days: |
8630 |
Low: |
5.13 |
|
RSI |
RSI(14):
|
33.77 |
Change(%): |
-25.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.470 |
Return on Equity (ttm) |
-133.4 |
Shares Out. (M) |
28.37 |
|
EPS Est. Current Year |
-2.390 |
Return on Assets (ttm) |
-59.1 |
Shares Float (M) |
13.16 |
|
EPS Est. Next Year |
-0.540 |
PEG Ratio |
0.00 |
% Held by Insiders |
19.10 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
-33.5 |
% Held by Institutions |
29.11 |
|
Forward EPS |
-0.320 |
Gross Profit (p.s.) |
0.195 |
Shares Short (K) |
458 |
|
Book Value (p.s.) |
1.120 |
EBITDA (p.s.) |
-1.441 |
P/E |
-4.14 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.44 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-34.55 |
P/S |
664512704.00 |
|
Operating Margin |
-602.65 |
Levered Free Cash Flow
(M) |
-20.35 |
P/CF |
-5.00 |
|
|
|
|
|
|
